Laboratory Testing for Hepatitis A Diagnosis
Order IgM anti-HAV serology on serum or plasma to diagnose acute hepatitis A infection—this is the only test required for confirmation. 1
Primary Diagnostic Test
- IgM anti-HAV is the definitive diagnostic test for acute hepatitis A infection and becomes detectable 5-10 days before symptom onset in the majority of persons 1
- Serologic testing is mandatory because hepatitis A cannot be differentiated from other viral hepatitis types based on clinical or epidemiologic features alone 1
- The test remains positive for approximately 6 months after acute infection, though some patients may test positive for >1 year 1
Specimen Requirements
- Serum (clot or serum separator tube) or plasma (EDTA or plasma preparation tube) are acceptable specimens 1
- Transport at room temperature within 2 hours for optimal results 1
Additional Serologic Tests (Context-Dependent)
- Total anti-HAV (IgM + IgG combined): Used for epidemiologic studies or to determine immunity status in persons considering pre-exposure prophylaxis, but NOT for diagnosing acute infection 1
- IgG anti-HAV: Indicates past infection or vaccine-derived immunity; appears early in infection and persists for life, providing lifelong protection 1
Supporting Laboratory Tests
- Liver function tests (ALT/AST, bilirubin): While not diagnostic, elevated transaminases are present in 97.2% of acute hepatitis A cases 2
- Serum transaminase screening can reliably exclude acute HAV infection when normal, potentially avoiding unnecessary serologic testing 2
- Mean peak ALT in confirmed acute hepatitis A is approximately 1920 U/L 3
Molecular Testing (Limited Role)
- HAV RNA detection by nucleic acid amplification testing (NAAT) can detect virus in blood and stool during acute infection 1, 4
- Available only in research laboratories and not routinely used for clinical diagnosis 1
- May be useful for molecular epidemiologic investigations and outbreak source identification 4
Critical Interpretation Caveats
- False-positive IgM anti-HAV results occur, particularly with low-level positive results in populations with low hepatitis A prevalence 1, 3
- All confirmed cases of acute hepatitis A have anti-HAV IgM values >4.0 (on Architect platform), with mean values of 9.4 3
- Equivocal or low-level reactive results require clinical correlation: documented jaundice was present in 90% of confirmed cases 3
- When clinical information suggests alternative diagnosis and IgM is low-level positive, acute hepatitis A can likely be excluded 3